Skip to content
10-K

Annual Report

MUSTANG BIO, INC. MBIO

0001558370-25-003913

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Capex FY 2024 · Dec 31, 2024 $0
Capex FY 2024 · Dec 31, 2023 $64K
Shares Diluted restated FY 2024 · Dec 31, 2023 172.03K sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$49.48M
Cash And Equivalents FY 2024 · Dec 31, 2023 $6.23M
Current Liabilities FY 2024 · Dec 31, 2023 $15.37M
Total Liabilities FY 2024 · Dec 31, 2023 $17.62M
Current Assets FY 2024 · Dec 31, 2023 $11.35M
Total Assets FY 2024 · Dec 31, 2023 $17.74M
Eps Diluted restated FY 2024 · Dec 31, 2023 −$299.95
Eps Basic restated FY 2024 · Dec 31, 2023 −$299.95
Sga Expense FY 2024 · Dec 31, 2023 $9.69M
Net Income FY 2024 · Dec 31, 2023 −$51.6M
Operating Income FY 2024 · Dec 31, 2023 −$49.26M
Stockholders Equity FY 2024 · Dec 31, 2022 $46.27M